Clinical Trial

Persistence of Sensitization to Contrast Media

Study acronym: PersensPC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the persistence of IgE-mediated allergy to contrast media (CM) after a second exposure in patients who tested positive at both the first and second evaluations for CM allergy. It also aims to analyze the risk factors associated with the persistence of IgE-mediated sensitization after the second allergological assessment.
Trial Details
NCT Number NCT07409051
Lead Sponsor University Hospital, Montpellier
Conditions Contrast Media Allergy
Enrollment 100 participants
Start Date 2026-02
Primary Completion 2028-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-02-13